Copley Scientific supplies a range of equipment, software and services for inhaled product testing for every stage of development and manufacture, of both innovator and generic products, topical and systemic. It additionally provides test instrumentation for other dosage forms.
Associated CompaniesNovi Systems
Copley Scientific Ltd
Colwick Quays Business Park
Phone / ContactT: +44 115 961 6229
F: +44 115 961 7637
E: [email protected]
Copley Scientific is a manufacturer of inhaler test equipment and provider of test instrumentation for other pharmaceutical dosage forms.
Copley Scientific was founded in 1946 in Nottingham, UK, by Frank Copley, to supply laboratory equipment to the local pharmaceutical industry. Today it is still family owned and managed. The focus on pharmaceutical test instrumentation began in 1957. Subsequent decades saw marked expansion and today the company manufactures a range of innovative equipment for tablet dissolution, disintegration, friability and hardness testing, and for testing creams, ointments, powders, suppositories and transdermal patches.
The 1980s saw respiratory drug delivery gain commercial momentum and, in parallel, the development of new solutions for the testing of orally inhaled and nasal drug products (OINDPs). Early success was boosted in 2000, with the signing of a strategic partnership agreement with MSP Corporation (Shoreview, MN, US) which enabled Copley Scientific to become the first company to offer the full range of cascade impactors specified by the US and European Pharmacopoeias for measuring the aerodynamic particle size distribution for all OINDPs.
The comprehensive range for inhaled product testing now extends to equipment, software and services for every stage of development and manufacture, of both innovator and generic products, topical and systemic.
In 2019, Copley Scientific acquired Novi Systems, a company with market-leading expertise in the automation of inhaler testing, extending the Copley product range and securing a broader platform for the development of new inhaler testing solutions.
Company headquarters remains in Nottingham, UK, in a purpose-built facility, with a well-established sales and service company in Switzerland and secure partnerships in place to serve dynamic and growing international markets.